The predictive value of cord blood 25-hydroxyvitamin D and vitamin A levels for bronchopulmonary dysplasia in preterm infants
- 1Department of Neonatology, Sichuan Provincial Clinical Medical Research Center for Birth Defects, Affiliated Hospital of Southwest Medical University, Sichuan, China
- 2Department of Neonatology, Southern Central Hospital of Yunnan Province, The First People's Hospital of Honghe State, Yunnan Province, China
Abstract
BackgroundDespite substantial progress in the treatment of bronchopulmonary dysplasia (BPD), its overall incidence remains high, with increasing rates of moderate-to-severe cases. Reliable early biomarkers are urgently needed to facilitate timely intervention and optimize long-term prognosis.MethodsThis prospective cohort study enrolled 144 preterm infants with gestational age ≤32 weeks admitted to the neonatal intensive care unit from March 2021 to December 2024. Umbilical arterial blood was collected to detect 25(OH)D, vitamin A (VA), IL-6, PCT, and CRP levels. Infants were classified into BPD (n = 63) and non-BPD (n = 81) groups, and the BPD group was further stratified into Grade I, II, and III subgroups according to oxygen requirement and respiratory support. Group differences in biomarker levels and clinical variables were analyzed. Univariate and multivariate logistic regression models were constructed to identify independent BPD predictors. ROC curves, DeLong test, NRI, and IDI were applied to evaluate incremental predictive performance.ResultsCord blood 25(OH)D and VA were significantly decreased, while PCT was elevated in BPD infants (all P < 0.05). Within BPD subgroups, 25(OH)D gradually decreased and IL-6 increased with disease severity. Multivariate regression confirmed that cord blood 25(OH)D remained an independent protective factor for BPD after adjustment for gestational age, birth weight, and caffeine exposure (OR = 0.854, P < 0.001), whereas VA showed no independent predictive significance. The baseline clinical model yielded an AUC of 0.784. The addition of 25(OH)D significantly improved predictive efficacy to AUC = 0.857 (ΔAUC = 0.071, P = 0.001), with robust NRI and IDI improvements (both P < 0.001). Further inclusion of VA produced no additional predictive benefit.ConclusionUmbilical arterial 25(OH)D is a stable independent predictive biomarker for BPD and provides valuable incremental predictive value beyond conventional clinical parameters, supporting early risk stratification in preterm infants, whereas VA exhibits limited predictive utility.
Related
- Safety risk identification and family empowerment needs in home oxygen therapy for preterm infants with bronchopulmonary dysplasia: a qualitative study
- Diuretics for Management of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension in Preterm Infants-A Systematic Review.
- Effects of Neurally Adjusted Ventilatory Assist on Lung Ultrasound Aeration and Diaphragmatic Function in Extremely Preterm Infants With Evolving or Established Bronchopulmonary Dysplasia.
- Early Tracheal and Salivary miRNAs in Extremely Preterm Infants Predict Bronchopulmonary Dysplasia-Related Pulmonary Hypertension.
- Cord blood T-Cell imbalances as early predictors of bronchopulmonary dysplasia in extremely preterm neonates.
BibTeX
@article{zhang2026predictive,
title = {{The predictive value of cord blood 25-hydroxyvitamin D and vitamin A levels for bronchopulmonary dysplasia in preterm infants}},
author = {Xiaoxia Zhang and Chunmei Wan and Xiaomei Wang and Lan Jin and Shanshan Zhao and Xi Wang and Wenbin Dong},
journal = {Frontiers in Pediatrics},
year = {2026},
month = oct,
doi = {10.3389/fped.2026.1948901},
url = {https://doi.org/10.3389/fped.2026.1948901},
note = {CC BY},
}
RIS
TY - JOUR
TI - The predictive value of cord blood 25-hydroxyvitamin D and vitamin A levels for bronchopulmonary dysplasia in preterm infants
AU - Xiaoxia Zhang
AU - Chunmei Wan
AU - Xiaomei Wang
AU - Lan Jin
AU - Shanshan Zhao
AU - Xi Wang
AU - Wenbin Dong
PY - 2026
DA - 2026/10/28
JO - Frontiers in Pediatrics
DO - 10.3389/fped.2026.1948901
UR - https://doi.org/10.3389/fped.2026.1948901
AB - BackgroundDespite substantial progress in the treatment of bronchopulmonary dysplasia (BPD), its overall incidence remains high, with increasing rates of moderate-to-severe cases. Reliable early biomarkers are urgently needed to facilitate timely intervention and optimize long-term prognosis.MethodsThis prospective cohort study enrolled 144 preterm infants with gestational age ≤32 weeks admitted to the neonatal intensive care unit from March 2021 to December 2024. Umbilical arterial blood was collected to detect 25(OH)D, vitamin A (VA), IL-6, PCT, and CRP levels. Infants were classified into BPD (n = 63) and non-BPD (n = 81) groups, and the BPD group was further stratified into Grade I, II, and III subgroups according to oxygen requirement and respiratory support. Group differences in biomarker levels and clinical variables were analyzed. Univariate and multivariate logistic regression models were constructed to identify independent BPD predictors. ROC curves, DeLong test, NRI, and IDI were applied to evaluate incremental predictive performance.ResultsCord blood 25(OH)D and VA were significantly decreased, while PCT was elevated in BPD infants (all P < 0.05). Within BPD subgroups, 25(OH)D gradually decreased and IL-6 increased with disease severity. Multivariate regression confirmed that cord blood 25(OH)D remained an independent protective factor for BPD after adjustment for gestational age, birth weight, and caffeine exposure (OR = 0.854, P < 0.001), whereas VA showed no independent predictive significance. The baseline clinical model yielded an AUC of 0.784. The addition of 25(OH)D significantly improved predictive efficacy to AUC = 0.857 (ΔAUC = 0.071, P = 0.001), with robust NRI and IDI improvements (both P < 0.001). Further inclusion of VA produced no additional predictive benefit.ConclusionUmbilical arterial 25(OH)D is a stable independent predictive biomarker for BPD and provides valuable incremental predictive value beyond conventional clinical parameters, supporting early risk stratification in preterm infants, whereas VA exhibits limited predictive utility.
SN - 2296-2360
ER -